Hepatitis C and recurrent treatment-resistant acute ischemic stroke.
Hepatitis C and recurrent treatment-resistant acute ischemic stroke.
Proc (Bayl Univ Med Cent). 2013 Apr;26(2):182-4
Authors: Saxsena A, Tarsia J, Dunn C, Aysenne A, Shah B, Moore DF
Abstract
Since the introduction of recombinant tissue plasminogen activator and thrombolysis, acute ischemic stroke has become a treatable disorder if the patient presents within the 4.5-hour time window. Typically, sporadic stroke is caused by atherosclerotic disease involving large or small cerebral arteries or secondary to a cardioembolic source often associated with atrial fibrillation. In the over-65-year age group, more rare causes of stroke, such as antiphospholipid syndromes, are unusual; such stroke etiologies are mostly seen in a younger age group (<55 years). Here we describe acute ischemic stroke in three patients >65 years with hepatitis C-associated antiphospholipid antibodies. We suggest that screening for antiphospholipid disorders in the older patient might be warranted, with potential implications for therapeutic management and secondary stroke prevention.
PMID: 23543984 [PubMed]
Source: Baylor University Medical Center Proceedings - Category: Universities & Medical Training Authors: Saxsena A, Tarsia J, Dunn C, Aysenne A, Shah B, Moore DF Tags: Proc (Bayl Univ Med Cent) Source Type: research
More News: Antiphospholipid Syndrome | Atrial Fibrillation | Cardiology | Heart | Hepatitis | Hepatitis C | Hughes Syndrome | Ischemic Stroke | Stroke | Universities & Medical Training